Transcription factors and muscle cachexia: is there a therapeutic target?
Mitch
W E
WE
Renal Division, Emory University School of Medicine, Atlanta, GA 30322, USA. wmitch@emory.edu
Price
S R
SR
D000818:Animals; D002100:Cachexia / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D009124:Muscle Proteins / Q000096:biosynthesis; D018482:Muscle, Skeletal / Q000378:metabolism / Q000503:physiopathology*; D016328:NF-kappa B / Q000502:physiology*; D015533:Transcriptional Activation; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D009124:Muscle Proteins; D016328:NF-kappa B; D014409:Tumor Necrosis Factor-alpha